特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
737911

ボツリヌス毒素の世界市場:分析・シェア・動向・規模・予測

Botulinum Toxin Market, By Product (Type A & Type B), By Application (Therapeutics & Cosmetic) and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 106 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.14円
ボツリヌス毒素の世界市場:分析・シェア・動向・規模・予測
出版日: 2018年03月15日
発行: AnalystView Market Insights
ページ情報: 英文 106 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のボツリヌストキシン (ボツリヌス毒素) 市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、製品別・用途別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイルなどについて調査しております。

第1章 ボツリヌス毒素市場:概要

第2章 エグゼクティブ・サマリー

第3章 ボツリヌス毒素市場:主な市場動向

  • 市場促進要因
    • 促進要因の影響度
  • 市場抑制要因
    • 抑制要因の影響度
  • 市場機会
  • 市場の将来動向

第4章 ボツリヌス毒素市場:産業分析

  • ポーターのファイブフォース分析
  • 市場求心力の分析
  • 規制体制の分析

第5章 ボツリヌス毒素の市場環境

  • 市場シェア分析

第6章 ボツリヌス毒素市場:種類別

  • 概要
  • A型ボツリヌス毒素
    • 概要
    • 市場規模の分析・予測、年間成長率 (金額ベース、通算12年間分)
    • Dysport
    • Xeomin
    • Botox (ボトックス)
    • その他
  • B型ボツリヌス毒素
    • Myobloc
    • その他

第7章 ボツリヌス毒素市場:用途別

  • 概要
  • 治療用
  • 美容用

第8章 ボツリヌス毒素市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ)
    • 概要
    • 市場規模の分析・予測、年間成長率 (金額ベース、通算12年間分)
    • 国別分析
  • 欧州 (フランス、ドイツなど)
  • アジア太平洋地域 (中国、インドなど)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第9章 主要ベンダーの分析

  • Allergan
    • 企業概要
    • SWOT分析
    • 近年の主な動向
  • Ipsen Group
  • Medytox
  • Metabiologics

第10章 アナリストの全方位的分析

第11章 付録

図表

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PEST Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Botulinum Toxin Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • Table 10 Botulinum Toxin Market, by Product, 2014 - 2025 (USD Billion)
  • Table 11 Botulinum Toxin Market, by Application, 2014 - 2025 (USD Billion)
  • Table 12 Botulinum Toxin Market, by Geography, 2014 - 2025 (USD Billion)
  • Table 13 North America Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 14 U.S. Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 15 Canada Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 16 Europe Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 17 France Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 18 Germany Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 19 Asia Pacific Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 20 China Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 21 India Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 22 Latin America Botulinum Toxin Market, 2014 - 2025 (USD Billion)
  • Table 23 MEA Botulinum Toxin Market, 2014 - 2025 (USD Billion)

List of Figures

  • Figure 1 Research Methodology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Value Chain Analysis Analysis
  • Figure 6 Botulinum Toxin Market, by Product, 2014 - 2025 (USD Billion)
  • Figure 7 Botulinum Toxin Market, by Application, 2014 - 2025 (USD Billion)
  • Figure 8 Botulinum Toxin Market, by Geography, 2014 - 2025 (USD Billion)
目次
Product Code: AV164

Report Hightlights

The botulinum toxin market is estimated to represent a global market of USD 3.93 billion by 2017 with growth rate of 8.2%.

Botulinum toxin (also termed as miracle poison) is a type of poisonous biological substance, neurotoxic protein, produced by bacterium Clostridium botulinum species. This species is a gram-positive, spore-forming, anaerobic rod commonly found in soil, plants & in water. Botulinum toxin acts by interfering with neural transmission and blocks the release of acetylcholine which may cause muscle paralysis. This drug is injected into a patient using a 30-gauge 1-inch needle to the affected muscles.

Market Dynamics

Growing demand for minimally invasive treatment coupled with increasing therapeutic use of this toxin is further driving the market growth. For example, nowadays, botulinum toxins play a very important role in the management of medical conditions such as focal dystonias, hyperhidrosis, hypersalivation, headaches, and hemifacial spasm. Additionally, the list of possible use of this protein as therapeutic in various disease condition is rapidly expanding which will provide significant growth opportunities for this market to grow. However, high side effects and lack of reimbursement coverage for this treatment hampers the market growth to some extent. For example, most procedures are intended for an aesthetic purpose such as to reduce fat and wrinkles which are not covered by reimbursement policies.

Product Takeaway

The product segment is divided as Type A, and Type B. Type A segment is considered to generate a major chunk of the global industry, more than 96% of the revenue share is captured by this segment throughout the forecast period. Growing demand coupled with increasing government approvals of Type A botulinum toxins drive the segment growth. Type A segment is further categorized as Dysport, Xeomin, Botox, and other. Whereas, Myobloc is an example of type B preparation. In terms of end users, the market is categorized as Therapeutic, and Cosmetic applications. Among which, the cosmetic application is accounted for the highest share of the global market. In 2017, this segment achieved USD 2.62 billion and is projected to grow by 8.3% over the study period.

Regional Takeaway

Regionally, North America accounted for the 36.23% share of the global market in 2017. Growing demand for this treatment for aesthetic appearance coupled with increasing disposable income drives the regional growth. Whereas, Europe is projected to capture more than 26% share of the overall industry by 2025. Availability of effective botulinum treatments augments the growth in this region. For example, Dysport, the type A product available in Europe and is widely distributed in 500-unit vials which can be stored at room temperature. Trailed closely by the Asia Pacific, this region is expected to grow with a significant growth rate over the study period. Growing medical tourism industry coupled with increasing geriatric population is anticipated to support the growth. For example, according to the World Bank, more than 25.0% of the Japanese population is over 65 years of age.

Key Vendor Takeaway

Companies namely Allergan, Ipsen Group, Medytox, and Metabiologics are some of the key companies operating in this market. Growing research and activities in collaboration with government organizations helped these companies to attain the notable market position. For instance, in May 2016, Ipsen signed a partnership agreement with the Institute of Molecular and Cell Biology (IMCB) for the study of intracellular trafficking of the Botulinum neurotoxins in the neurons. The partnership is expected to help both the companies expand applications of botulinum toxins.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2014 & 2016

Base Year - 2017

Estimated Year - 2018

Projected Year - 2025

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Hospitals

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY PRODUCT

Type A

Dysport

Xeomin

Botox

Other

Type B

Myobloc

Others

MARKET, BY APPLICATION

Therapeutic

Cosmetic

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

TABLE OF CONTENTS

1. BOTULINUM TOXIN MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. BOTULINUM TOXIN KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. BOTULINUM TOXIN INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Market Attractiveness Analysis
  • 4.3. Regulatory Framework Analysis

5. BOTULINUM TOXIN MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. BOTULINUM TOXIN MARKET - BY ANIMAL TYPE

  • 6.1. Overview
  • 6.2. Type A
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 6.2.3. Dysport
    • 6.2.3.1. Overview
    • 6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 6.2.4. Xeomin
    • 6.2.4.1. Overview
    • 6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 6.2.5. Botox
    • 6.2.5.1. Overview
    • 6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 6.2.6. Other
    • 6.2.6.1. Overview
    • 6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.3. Type B
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 6.3.3. Myobloc
    • 6.3.3.1. Overview
    • 6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 6.3.4. Others
    • 6.3.4.1. Overview
    • 6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

7. BOTULINUM TOXIN MARKET - BY APPLICATION

  • 7.1. Overview
  • 7.2. Therapeutic
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.3. Cosmetic
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

8. BOTULINUM TOXIN MARKET- BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.2.3. U.S.
    • 8.2.3.1. Overview
    • 8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.2.4. Canada
    • 8.2.4.1. Overview
    • 8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.3. France
    • 8.3.3.1. Overview
    • 8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.4. Germany
    • 8.3.4.1. Overview
    • 8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.5. Rest of Europe
    • 8.3.5.1. Overview
    • 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.3. China
    • 8.4.3.1. Overview
    • 8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.4. India
    • 8.4.4.1. Overview
    • 8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.5. Rest of APAC
    • 8.4.5.1. Overview
    • 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.5. Rest of the World
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.5.3. Latin America
    • 8.5.3.1. Overview
    • 8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.5.4. Middle East and Africa
    • 8.5.4.1. Overview
    • 8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

9. KEY VENDOR ANALYSIS

  • 9.1. Allergan
    • 9.1.1. Company Overview
    • 9.1.2. SWOT Analysis
    • 9.1.3. Key Developments
  • 9.2. Ipsen Group
    • 9.2.1. Company Overview
    • 9.2.2. SWOT Analysis
    • 9.2.3. Key Developments
  • 9.3. Medytox
    • 9.3.1. Company Overview
    • 9.3.2. SWOT Analysis
    • 9.3.3. Key Developments
  • 9.4. Metabiologics
    • 9.4.1. Company Overview
    • 9.4.2. SWOT Analysis
    • 9.4.3. Key Developments

Client can request additional company profiling as per specific requirements

10. 360 DEGREE ANALYSTVIEW

11. APPENDIX

  • 11.1. Research Methodology
  • 11.2. Abbreviations
  • 11.3. Disclaimer
  • 11.4. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.